Literature DB >> 3089843

Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.

K Koizumi, T Aono.   

Abstract

Two patients with prolactinomas who could not tolerate a large dose of bromocriptine were treated with combination of bromocriptine and tamoxifen. This combined therapy normalized the PRL level and restored a regular ovulatory cycle, which resulted in pregnancy.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3089843     DOI： 10.1016/s0015-0282(16)49531-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Use of tamoxifen before and during pregnancy.

Authors:  Geert Braems; Hannelore Denys; Olivier De Wever; Veronique Cocquyt; Rudy Van den Broecke
Journal:  Oncologist       Date:  2011-10-21

Review 3.  Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases.

Authors:  Barbara Buonomo; Antonella Brunello; Stefania Noli; Loredana Miglietta; Lucia Del Mastro; Matteo Lambertini; Fedro Alessandro Peccatori
Journal:  Breast Care (Basel)       Date:  2019-07-25       Impact factor: 2.860

Review 4.  Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.

Authors:  M R Boland; N P Tatonetti
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

5.  Tamoxifen Exerts Anticancer Effects on Pituitary Adenoma Progression via Inducing Cell Apoptosis and Inhibiting Cell Migration.

Authors:  Tingting Lv; Zirui Zhang; Haoying Yu; Shuyue Ren; Jingrong Wang; Shang Li; Lan Sun
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.